Biodexa Pharmaceuticals Cash from Financing (TTM) Trends

Biodexa Pharmaceuticals Plc (BDRX)

1.30 +0.58 (+79.36%) USD | NASDAQ | Apr 26, 16:00

1.21 -0.09 (-6.92%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	12.76M
June 30, 2023	7.972M
December 31, 2022	0.0489M
June 30, 2022	11.88M
December 31, 2021	11.87M
June 30, 2021	3.448M
December 31, 2020	4.039M
June 30, 2020	8.850M
December 31, 2019	24.10M
June 30, 2019	7.797M

Date	Value
December 31, 2018	-8.350M
June 30, 2018	13.35M
December 31, 2017	13.65M
June 30, 2017	19.03M
December 31, 2016	18.92M
June 30, 2016	-0.6557M
December 31, 2015	-0.3313M
June 30, 2015	51.94M
December 31, 2014	54.42M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.0489M

Minimum

Dec 2022

24.10M

Maximum

Dec 2019

9.276M

Average

8.411M

Median

Cash from Financing (TTM) Benchmarks